High KCNA5 expression correlates with decreased survival rates in STAD patients (long-rank p = 0.023) (Figure 2M), while it has no association with survival in SKCM, UCEC, LUAD, and LUSC cancers (Figure 2K,L,N,O). This evidence concerns the gene KCNA5 and gastric adenocarcinoma.